COVID-19 drug discovery and treatment options
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused substantial morbidity and …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused substantial morbidity and …
COVID-19 therapeutics: Challenges and directions for the future
PC Robinson, DFL Liew, HL Tanner… - Proceedings of the …, 2022 - National Acad Sciences
The emergence of SARS-CoV-2 triggering the COVID-19 pandemic ranks as arguably the
greatest medical emergency of the last century. COVID-19 has highlighted health disparities …
greatest medical emergency of the last century. COVID-19 has highlighted health disparities …
A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals
VC Chitalia, AH Munawar - Journal of translational medicine, 2020 - Springer
While the COVID-19 pandemic has spurred intense research and collaborative discovery
worldwide, the development of a safe, effective, and targeted antiviral from the ground up is …
worldwide, the development of a safe, effective, and targeted antiviral from the ground up is …
Therapeutic strategies for COVID-19: progress and lessons learned
G Li, R Hilgenfeld, R Whitley, E De Clercq - Nature Reviews Drug …, 2023 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …
Revisiting potential druggable targets against SARS‐CoV‐2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review
Abstract Coronavirus disease‐19 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), is one of the most contagious diseases in human …
syndrome coronavirus 2 (SARS‐CoV‐2), is one of the most contagious diseases in human …
An Update on SARS-CoV-2 Clinical Trial Results—What We Can Learn for the Next Pandemic
BY Arman, J Brun, ML Hill, N Zitzmann… - International Journal of …, 2023 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic has claimed over 7 million lives
worldwide, providing a stark reminder of the importance of pandemic preparedness. Due to …
worldwide, providing a stark reminder of the importance of pandemic preparedness. Due to …
COVID-19: a defining moment for clinical pharmacology?
PH van der Graaf, KM Giacomini - 2020 - cabidigitallibrary.org
Though most drug development takes years from discovery to approval, for the COVID-19
pandemic, drug development is on a fundamentally different timeline. Broadly speaking …
pandemic, drug development is on a fundamentally different timeline. Broadly speaking …
Therapeutics for COVID-19
SS Toussi, JL Hammond, BS Gerstenberger… - Nature …, 2023 - nature.com
Vaccines and monoclonal antibody treatments to prevent severe coronavirus disease 2019
(COVID-19) illness were available within a year of the pandemic being declared but there …
(COVID-19) illness were available within a year of the pandemic being declared but there …
Current and future therapeutical approaches for COVID-19
Coronavirus 2019 (COVID-19), the WHO-classified novel coronavirus of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly become a global pandemic …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly become a global pandemic …
Update on antiviral strategies against COVID-19: unmet needs and prospects
CH Liu, CH Lu, SH Wong, LT Lin - Frontiers in Immunology, 2021 - frontiersin.org
By December 2020, the COVID-19 pandemic had caused more than 74 million confirmed
cases and 1.6 million related deaths around the world. However, only a few drugs have …
cases and 1.6 million related deaths around the world. However, only a few drugs have …